Isracann Biosciences Inc (ISCNF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Isracann Biosciences Total Liabilities (Quarterly): 2.990M for Aug. 31, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2022 | 2.990M |
| May 31, 2022 | 3.003M |
| February 28, 2022 | 0.5863M |
| November 30, 2021 | 0.6042M |
| August 31, 2021 | 0.3645M |
| May 31, 2021 | 0.3852M |
| February 28, 2021 | 0.8756M |
| November 30, 2020 | 0.7371M |
| August 31, 2020 | 0.9226M |
| May 31, 2020 | 1.239M |
| February 29, 2020 | 0.8906M |
| November 30, 2019 | 1.466M |
| August 31, 2019 | 0.7366M |
| May 31, 2019 | 0.7689M |
| February 28, 2019 | 0.6582M |
| November 30, 2018 | 0.6078M |
| August 31, 2018 | 0.5037M |
| May 31, 2018 | 0.6957M |
| February 28, 2018 | 0.5282M |
| November 30, 2017 | 0.096M |
| August 31, 2017 | 0.7025M |
| May 31, 2017 | 0.6872M |
| February 28, 2017 | 0.7121M |
| November 30, 2016 | 0.8472M |
| Date | Value |
|---|---|
| August 31, 2016 | 0.8705M |
| May 31, 2016 | 0.3429M |
| February 29, 2016 | 0.2502M |
| August 31, 2015 | 0.1056M |
| May 31, 2015 | 0.0649M |
| February 28, 2015 | 0.0222M |
| November 30, 2014 | 0.0261M |
| August 31, 2014 | 0.0249M |
| May 31, 2014 | 0.0317M |
| February 28, 2014 | 0.0108M |
| November 30, 2013 | 0.0118M |
| August 31, 2013 | 0.0144M |
| May 31, 2013 | 0.0147M |
| February 28, 2013 | 0.0048M |
| November 30, 2012 | 0.0058M |
| August 31, 2012 | 0.0176M |
| May 31, 2012 | 0.0132M |
| February 29, 2012 | 0.0053M |
| November 30, 2011 | 0.009M |
| August 31, 2011 | 0.0188M |
| May 31, 2011 | 0.0165M |
| February 28, 2011 | 0.0052M |
| November 30, 2010 | 0.0055M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.3645M
Minimum
Aug 2021
3.003M
Maximum
May 2022
1.112M
Average
0.8222M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
| Liminal Biosciences Inc (DELISTED) | 7.790M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.085M |
| Shareholders Equity (Quarterly) | 0.0979M |